{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T05:25:03Z","timestamp":1749792303265,"version":"3.41.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.reumae.2025.501870","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T23:09:02Z","timestamp":1748646542000},"page":"501870","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Capecitabine-induced sarcoidosis in an oncology patient: Clinical presentation with arthritis"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8248-3686","authenticated-orcid":false,"given":"Yedra","family":"Us\u00f3n-Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e1tima","family":"Mocha-Campillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maialen","family":"Guerrero-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Lao-Romera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina Soledad","family":"Moreno-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reumae.2025.501870_bib0005","series-title":"StatPearls","article-title":"Sarcoidosis","author":"Bokhari","year":"2023"},{"key":"10.1016\/j.reumae.2025.501870_bib0010","article-title":"Advance in pathogenesis of sarcoidosis: Triggers and progression","volume":"10","author":"Chen","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.reumae.2025.501870_bib0015","article-title":"Sarcoidosis and autoimmune inflammatory syndrome induced by adjuvants","volume":"13","author":"Starshinova","year":"2023","journal-title":"Life (Basel, Switzerland)"},{"key":"10.1016\/j.reumae.2025.501870_bib0020","unstructured":"Moriano Morales C. IGF. Sarcoidosis. In: Andr\u00e9u S\u00e1nchez JL, Cuadrado Lozano MJ, editors. Tratado SER de diagn\u00f3stico y tratamiento de Enfermedades Autoinmunes Sist\u00e9micas. 2a edici\u00f3n, Madrid: Ergon; 223d. C., pp. 477\u2013482."},{"key":"10.1016\/j.reumae.2025.501870_bib0025","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3390\/cells10040766","article-title":"Sarcoidosis: a clinical overview from symptoms to diagnosis","volume":"10","author":"S\u00e8ve","year":"2021","journal-title":"Cells."},{"key":"10.1016\/j.reumae.2025.501870_bib0030","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.chest.2018.03.056","article-title":"Drug-induced sarcoidosis-like reactions","volume":"154","author":"Chopra","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.reumae.2025.501870_bib0035","first-page":"158","article-title":"Perfil de seguridad de capecitabina formulaci\u00f3n innovadora y formulaci\u00f3n gen\u00e9rica en adyuvancia del c\u00e1ncer colorrectal no metast\u00e1sico","volume":"43","author":"S\u00e1nchez-Gund\u00edn","year":"2019","journal-title":"Farm Hosp"},{"key":"10.1016\/j.reumae.2025.501870_bib0040","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4046\/trd.2012.72.3.318","article-title":"A case of capecitabine-induced sarcoidosis","volume":"72","author":"Kang","year":"2012","journal-title":"Tuberc Respir Dis"},{"year":"2024","series-title":"A case of sarcoidosis associated with capecitabine","author":"Birel","key":"10.1016\/j.reumae.2025.501870_bib0045"},{"key":"10.1016\/j.reumae.2025.501870_bib0050","unstructured":"eHealthMe. Capecitabine and sarcoidosis \u2014 a phase IV clinical study of FDA data. [Accessed 20 January 2025]. Available from: https:\/\/www.ehealthme.com\/ds\/capecitabine\/sarcoidosis\/."}],"container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574325000668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574325000668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T13:39:05Z","timestamp":1749562745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173574325000668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2173574325000668"],"URL":"https:\/\/doi.org\/10.1016\/j.reumae.2025.501870","relation":{},"ISSN":["2173-5743"],"issn-type":[{"type":"print","value":"2173-5743"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Capecitabine-induced sarcoidosis in an oncology patient: Clinical presentation with arthritis","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reumae.2025.501870","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.reuma.2025.501870","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de Reumatolog\u00eda (SER), Colegio Mexicano de Reumatolog\u00eda (CMR) and Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"501870"}}